VLP Therapeutics Japan is a biotech company dedicated to developing innovative vaccine technologies for the treatment of diseases that currently lack effective treatment. Vaccines are crucial for eradicating epidemic and pandemic diseases, saving millions of lives. With a commitment to improving global public health, VLP Therapeutics has developed the i-αVLP vaccine technology, which holds great potential for creating breakthrough treatments.

Their platform technologies include Surface Antigen Display, Interior Gene Delivery, and Native Virus Modification, which enable the development of cancer vaccines, malaria vaccines, and dengue vaccines. The company has recently raised funding for the development of cancer and infectious disease vaccines and the establishment of an investigational vaccine manufacturing facility. With its cutting-edge research and collaborations with global partners, VLP Therapeutics Japan is at the forefront of revolutionizing the field of vaccine technology